Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine
2026-07-27

Yoshida AH-130 ascites hepatomacancer cachexiaformoterolmuscle wastingβ2-adrenergic agonist
Abstract. Cancer cachexia occurs in the majority of cancer patients before death, and it is responsible for the death of 22% of cancer patients. One of the most relevant characteristics of cachexia is that of asthenia, which reflects significant muscle wasting noted in cachectic cancer patients The aim of the present study was to assess whether the β2-adrenergic agonist formoterol is associated with an improvement in physiological parameters such as grip force and total physical activity in cachetic rats. Administration of the β2-agonist formoterol (0.3 mg/kg for 7 days) in rats bearing Yoshida AH-130 ascites hepatoma tumors, a model which induces a strong loss of both body and muscle weight, resulted in a significant reversal of the muscle wasting process, as reflected by individual muscle weights. The anti-wasting effects of the drug were also observed in terms of total physical activity and grip force, thus resulting in an improvement in physical performance in cachectic tumor-bearing rats.
1
Cancer cachexia causes significant muscle wasting and asthenia, contributing to death in 22% of cancer patients.
2
Formoterol (β2-adrenergic agonist) administered at 0.3 mg/kg for 7 days reverses muscle wasting in rats bearing Yoshida AH-130 ascites hepatoma.
3
Formoterol improved physiological performance measures, increasing total physical activity and grip force in cachectic rats.
4
Formoterol treatment produced significant increases in individual muscle weights in cachectic tumor-bearing rats.

Cachectic rats bearing Yoshida AH-130 ascites hepatoma tumors

Effects of the β2-adrenergic agonist formoterol (0.3 mg/kg for 7 days) on muscle wasting and physical performance, specifically grip force, total physical activity, and individual muscle weights

Publication Details
Publication Date
2026-07-27
Journal
Publisher
ISSN
Cited by
1741
Access Type
Author Information
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%